Clinuvel Pharmaceuticals Ltd (CUVL) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering drugs for the treatment of patients with severe genetic and skin disorders worldwide. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with EPP in the People's Republic of China. The company was founded in 1987 and is headquartered in Melbourne, Australia.
No case yet. It builds on the next filing, report or 13F period.
No peer readings for Clinuvel Pharmaceuticals Ltd yet.
No institutional manager reports a position in this company. Funds disclose holdings quarterly on form 13F, and none of them names it.
each tick is a filing
Clinuvel Pharmaceuticals Ltd
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Services
Prev close 5.92 · gapped above the open, never looked back. High/low 6.01 at 3:45 pm ET, 6.00 at 11:15 am ET.
CUVL (Clinuvel Pharmaceuticals Ltd) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.